QUCY

Quantum Cyber NV

0.7007

Nov 10 • 1:23 PM ET +0.0171 (2.50%)

Healthcare Diagnostics & Research USA Micro NASD

Peers: IMDX ARQQ QNC LAES UMAC IONQ INFQ QBTS RGTI XNDU

Index	-
Market Cap	61.11M
Enterprise Value	47.96M
Income	-
Sales	-
Book/sh	0.81
Cash/sh	0.15
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	13
IPO	Nov 05, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.86
P/C	4.57
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	5.56
Current Ratio	5.56
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-0.49
EPS next Q	-0.08
EPS this Y	-
EPS next Y	-
EPS next 5Y	79.59%
EPS past 3/5Y	66.90% 8.38%
Sales past 3/5Y	0.45% 1.70%
EPS Y/Y TTM	11.95%
Sales Y/Y TTM	-
EPS Q/Q	97.59%
Sales Q/Q	-100.00%
Earnings	-
EPS/Sales Surpr.	- -58.95%

Insider Own	69.87%
Insider Trans	0.00%
Inst Own	0.27%
Inst Trans	-11.85%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-21.53%
SMA50	-40.10%
SMA200	-41.29%
Trades

Shs Outstand	87.22M
Shs Float	26.28M
Short Float	4.75%
Short Ratio	2.08
Short Interest	1.25M
52W High	4.93 -85.79%
52W Low	0.30 133.57%
Volatility	11.14% 11.07%
ATR (14)	0.09
RSI (14)	30.25
Beta	2.45
Rel Volume	0.52
Avg Volume	600.45K
Volume	194,172

Perf Week	-3.19%
Perf Month	-31.97%
Perf Quarter	-46.31%
Perf Half Y	117.07%
Perf YTD	-37.44%
Perf Year	-46.92%
Perf 3Y	-99.22%
Perf 5Y	-99.80%
Perf 10Y	-
Recom	1.00
Target Price	9.00
Prev Close	0.68
Price	0.70
Change %	2.50%

Consensus

Strong Buy

Avg. Price Target

$9.00

Implied Upside

+1,184.4%

Analysts3incl. previous ratings

Rating Distribution1 Buy · 2 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Feb 14, 2025	Initiated	MMaxim Group	Buy	$14	+1,898.0%
Nov 25, 2024	Downgrade	HH.C. Wainwright	Buy → Neutral
Nov 21, 2023	Downgrade	CCantor Fitzgerald	Overweight → Neutral
Jun 21, 2022	Initiated	HH.C. Wainwright	Buy	$25	+3,467.9%

Nov-03-26 07:30AM	Quantum Cyber Is Pursuing an Alternative as GPS Can Be Turned Against Drones (NASDAQ: QUCY) (FinanceWire)
Oct-15-26 09:06AM	Quantum Cyber (QUCY), Peers Pull Senior Defense Talent as Trump Strategic Program Gathers Pace (FinanceWire) +5.83%
Oct-08-26 09:55AM	Precision Agriculture's Drone Revolution Flying High within Multi-Billion Dollar DaaS Industry (PR Newswire)
Sep-17-26 09:15AM	The Drone Arms Race Is Here: Military UAV Market Projected to Triple by 2032 (PR Newswire)
Sep-07-26 08:45AM	Quantum Cyber: Taking Aim at the Multi-Billion-Dollar GPS Problem on the Modern Battlefield (Nasdaq: QUCY) (FinanceWire)
09:46AM	Loading…
Sep-03-26 09:46AM	Precision Agriculture Goes Airborne as Drone Surveying Market Accelerates Toward Double-Digit Growth (PR Newswire) -5.00%
Aug-11-26 07:55AM	Quantum Cyber N.V. Receives $9 Price Target and New 'Buy' Rating From Litchfield Hills Analyst (NASDAQ: QUCY) (FinanceWire)
Aug-03-26 10:51AM	StreetWatch: As Federal Funding Floods the Drone Market, Quantum Cyber Is Assembling a Next Generation Platform (Newsfile) +10.53%
08:55AM	As Federal Funding Floods the Drone Market, Quantum Cyber N.V. Is Worth Watching (Nasdaq: QUCY) (FinanceWire)
Jul-16-26 08:44AM	Quantum Cyber shares rise after subsidiary secures $2.1 million in new orders (QUCY) (InvestorsHub)
Jul-09-26 03:41PM	Quantum Cyber Addresses Short Seller Biased Report (Stocktwits) +5.93%
Jul-06-26 09:16AM	Quantum Cyber Sets 100,000-Drone Annual Production Goal for Planned Connecticut Facility (QUCY) (InvestorsHub)
Jun-29-26 01:17PM	Short-Seller White Diamond Research Expects Serious Dilution Risk' For This Small-Cap Pharma-Turned-Defense Play (Stocktwits)
Jun-26-26 09:36AM	QUCYs Ambitions Of Acquiring SpaceX Equity Stake Sends Stock Soaring CEO Says SPCX Is Central To The Future Of Defense Technology (Stocktwits) +12.41%
Jun-04-26 01:57PM	QUCY Stock Tumbled Nearly 8% Today Whats Driving The Fall? (Stocktwits) -5.28%
09:20AM	Loading…
Jun-03-26 09:20AM	Drones-as-a-Service Market Surges as AI, Automation, and Industrial Demand Drive Billion-Dollar Growth (PR Newswire)
May-21-26 09:30AM	Drones-Led Disruption Accelerates as Commercial Adoption Surges Across Industrial Markets (PR Newswire) +8.21%
May-14-26 09:10AM	Military Drone Sector Eyes Massive Growth as Nations Modernize Defense Operations (PR Newswire) +123.88%
Mar-17-26 08:30AM	Quantum Cyber Aligns Strategy With Trump Administration's National Cyber Security Framework, Targets Acquisitions in Quantum and Cyber Defense Sectors (GlobeNewswire) -17.75%
Mar-13-26 07:30AM	Quantum Cyber (f/k/a Mainz Biomed) Announces Stock Ticker Symbol Change to NASDAQ: QUCY (GlobeNewswire)
Mar-11-26 07:30AM	Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors (GlobeNewswire)
Feb-24-26 07:30AM	Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples (GlobeNewswire)
Feb-17-26 07:30AM	Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update (GlobeNewswire) -15.57%
Jan-14-26 09:15AM	Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting (GlobeNewswire)
Jan-05-26 09:15AM	Mainz Biomed Provides Review of 2025 Highlights (GlobeNewswire) +9.48%
Dec-12-25 09:51AM	2 Small-Cap Biotechs That Could Reward Patient Investors (MarketBeat)
Dec-02-25 08:01AM	DoctorBox Adds Mainz Biomed's ColoAlert(R) to Its Portfolio (GlobeNewswire)
Nov-18-25 08:01AM	Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America (GlobeNewswire)
Nov-12-25 08:01AM	Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025 (GlobeNewswire)
Nov-10-25 08:01AM	Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS) (GlobeNewswire)
09:01AM	Loading…
Oct-15-25 09:01AM	Mainz Biomed to Attend 2025 Maxim Growth Summit (GlobeNewswire)
Oct-08-25 09:00AM	Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project (GlobeNewswire)
Sep-30-25 08:01AM	Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting (GlobeNewswire)
Sep-23-25 08:01AM	Mainz Biomed Announces Commercial Launch of ColoAlert in Switzerland (GlobeNewswire)
Sep-02-25 08:01AM	Mainz Biomed Announces Registration of ColoAlert in the United Kingdom (GlobeNewswire)
Aug-13-25 08:01AM	Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert (GlobeNewswire) +17.01%
Aug-04-25 10:22AM	Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants (GlobeNewswire) +6.77%
Jul-23-25 08:01AM	Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies (GlobeNewswire)
Jul-15-25 08:01AM	Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition (GlobeNewswire) +7.03%
Jun-25-25 08:01AM	Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test (GlobeNewswire)
Jun-11-25 06:42AM	Mainz begins next phase of project to develop pancreatic cancer blood test (Medical Device Network)
Jun-10-25 09:01AM	Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project (GlobeNewswire)
May-21-25 06:00AM	Will AI Empower the PR Industry or Create Endless Seas of Spam? (The Wall Street Journal) -10.30%
May-19-25 08:01PM	Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants (GlobeNewswire) -9.43% +5.43%
May-16-25 08:01AM	Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study (GlobeNewswire) +7.49%
Apr-29-25 08:01AM	Mainz Biomed Enters into Technology Partnership with EDX Medical Group (GlobeNewswire)
Apr-28-25 08:01AM	Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval (GlobeNewswire)
Apr-01-25 08:01AM	Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -8.72%
Mar-28-25 06:49AM	Mainz enrols first subject in study to evaluate colorectal cancer test (Medical Device Network) -9.78%
Mar-27-25 09:01AM	Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study (GlobeNewswire) -7.07%
Mar-20-25 10:35AM	Monte Rosa Therapeutics (GLUE) Q4 Earnings and Revenues Top Estimates (Zacks) +12.41%
Mar-19-25 05:35PM	Immunome, Inc. (IMNM) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Mar-13-25 08:01AM	Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer (GlobeNewswire)
Mar-03-25 08:01AM	Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention (GlobeNewswire)
Feb-20-25 08:01AM	Mainz Biomed Expands into Switzerland with labor team w (GlobeNewswire) +7.28%
Feb-11-25 08:01AM	Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month (GlobeNewswire) +11.28%
Jan-27-25 08:01AM	Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements (GlobeNewswire) +10.79%
Jan-21-25 08:01AM	Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population (GlobeNewswire)
Dec-20-24 10:31AM	Mainz Biomed partners with Quest for colorectal cancer screening test (Medical Device Network) +40.04%
Dec-19-24 08:01AM	Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test (GlobeNewswire) +26.19%
Dec-16-24 05:00PM	Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering (GlobeNewswire) -11.69% -6.62%
Dec-12-24 08:00PM	Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules (GlobeNewswire) +6.26%
Nov-29-24 08:45AM	Mainz Biomed Announces Stock Split (GlobeNewswire) -14.06%
Nov-13-24 07:23PM	The Oncology Bet Is Already Paying Off For Pfizer (Benzinga) -9.65%
Nov-12-24 09:00AM	Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets (GlobeNewswire) +28.70%
Oct-22-24 08:10AM	Mainz Biomed restructured operations, implemented cost reductions (TipRanks) +5.09%
Oct-21-24 08:01AM	Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-10-24 05:37PM	Mainz Biomed Secures Additional $1.5M Funding (TipRanks) -13.95%
Oct-08-24 08:01AM	Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version (GlobeNewswire) +7.61%
Oct-01-24 02:11PM	The Covid Era Tech Promises To Reinvent Cancer Treatment (Benzinga)
08:01AM	Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 (GlobeNewswire)
Sep-20-24 10:48AM	Pfizer Advances On Its Cancer Journey (Benzinga)
Sep-18-24 08:01AM	Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador (GlobeNewswire) -7.36%
Sep-04-24 04:01AM	Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert (GlobeNewswire) -9.39%
Jul-30-24 12:09PM	Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer (Benzinga)
Jul-25-24 08:01AM	Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience (GlobeNewswire)
Jul-19-24 12:38PM	Mainz BioMed Seeks FDA Breakthrough Device Designation for Advanced Colorectal Cancer Test (News Direct) -8.16%
Jul-10-24 04:12AM	Mainz Biomed seeks FDA breakthrough device status for colorectal cancer test (Medical Device Network) -15.52%
Jul-09-24 07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
03:01AM	Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test (GlobeNewswire)
Jul-02-24 01:38PM	mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment (Benzinga)
08:01AM	Mainz Biomed Provides Half Year 2024 Corporate Update (GlobeNewswire)
Jun-04-24 01:45PM	Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon (Benzinga) -16.36%
Jun-03-24 08:01AM	Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024 (GlobeNewswire)
May-31-24 05:01PM	Mainz Biomed Reports Results of 2024 Annual General Meeting (GlobeNewswire) +20.39%
May-29-24 07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-28-24 08:01AM	Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting (GlobeNewswire) +32.94%
May-20-24 08:01AM	Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial (GlobeNewswire) -9.03%
May-17-24 07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace) +5.90%
May-16-24 10:51AM	Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game (Benzinga)
May-07-24 08:01AM	Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C. (GlobeNewswire) +5.97%
Apr-29-24 12:02PM	mRNA Is Promising A Breakthrough In Fighting Cancer (Benzinga) +5.98%
Apr-25-24 09:29AM	Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic (GlobeNewswire)
Apr-10-24 12:47PM	The Pharmaceutical Industry Finds Itself At A Historical Crossroads (Benzinga) +6.06%
Apr-09-24 09:53PM	MYNZ Stock Earnings: Mainz Biomed Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -8.33%
08:01AM	Mainz Biomed Reports Full Year 2023 Financial Results (GlobeNewswire)
Mar-19-24 08:01AM	Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment (GlobeNewswire)
Mar-18-24 08:01AM	Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options (GlobeNewswire)
Mar-12-24 08:01AM	Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations (GlobeNewswire)
Mar-08-24 12:00PM	What Makes Mainz Biomed NV (MYNZ) a New Buy Stock (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BAECHLER GUIDO	Officer	May 22 '26	Proposed Sale	3.77	240,000	904,800		May 22 12:32 PM
BAECHLER GUIDO	Policy-Making Officer	May 15 '26	Proposed Sale	3.46	200,000	692,000		May 18 04:28 PM

Quantum Cyber NV engages in assembling an artificial intelligence (AI)-powered, quantum-accelerated system-of-systems autonomous defense platform. It integrates drone warfare, counter-UAS, autonomous naval mine countermeasures, EMP shielding, anti-drone ammunition, command-and-control, and quantum antenna applications. The company was founded on March 8, 2021 and is headquartered in West Palm Beach, FL.

CEO & DirectorMr. David Elliot Lazar

Ph.D.Dr. Christopher Von Toerne P.M.P.

Head of U.S. SalesMr. Dennis Schnur

Head of Human ResourcesMr. Stefan Erlach

Head of SalesMr. Tzvi Lev

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QUCY

Quantum Cyber NV

Upgrade your Finviz experience